BACK
|In Follow Up
Bavarian RSV
Phase 3 randomized, double- blind study comparing recombinant MVA-BN-RSV vaccine vs placebo for efficacy and safety in adults >=60 years of age.
Phase 3 randomized, double- blind study comparing recombinant MVA-BN-RSV vaccine vs placebo for efficacy and safety in adults >=60 years of age.